Article Reports Results from Independent Study Demonstrating Test's 100% Sensitivity and Specificity for IgM Antibodies and 96.7% and 97.5% Sensitivity and Specificity, Respectively, for IgG ...

The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes severe acute respiratory distress in a significant proportion of ...

Diagnostic or polymerase chain reaction (PCR) tests are currently being used to diagnose patients with COVID-19. Antibody tests allow for more accurate tracking of the spread of the coronavirus.

PALO ALTO, Calif.--(BUSINESS WIRE)--Nirmidas Biotech, Inc., a member of the StartX Med COVID-19 Task Force, announces its second FDA Emergency Use Authorization (EUA) for their COVID-19 rapid antibody ...

ENGLEWOOD, CO / ACCESSWIRE / April 15, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs ...

The analysis included results from 2 tests that have received EUA: the SARS-CoV-2 ELISA test (Euroimmun) and the COVID-19 IgG/IgM Rapid Test Cassette (Healgen). The Food and Drug Administration (FDA) ...

On November 6, China debuted a new travel testing policy. Before, incoming airline passengers had to submit results for a conventional PCR test that proved the absence of Covid-19 and, upon landing, ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use authorization to market a ...